Article
Sex differences in cardiomyocyte proteomic responses to the cardiotoxic chemotherapy drug doxorubicin
2026-04-24
Abstract excerpt
Anthracyclines, including doxorubicin, are widely used chemotherapeutic agents, but dose-dependent cardiotoxicity limits their clinical utility and increases the risk of heart failure in cancer survivors. In paediatric patients, female sex is a significant risk factor for anthracycline-associated cardiotoxicity, yet pre-clinical studies rarely investigate sex differences in immature hearts. Here, we provide a prot...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4abf998-73e4-50bf-a4f9-b76e3605b55b
- DOI
- 10.64898/2026.04.21.715711
